Human synthetic insulin may offer low-cost, effective treatment for certain patients with diabetes and financial constraints.
Jennifer N. Goldstein, MD, MSc
Advertisement
Articles by Jennifer N. Goldstein, MD, MSc
A care transitions program for patients who underwent percutaneous coronary intervention appeared to reduce 30-day rehospitalizations for patients with Medicaid who lived in wealthier zip codes.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
2
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
3
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
4
Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk
5